Should incentive spirometry, ezPAP (expiratory positive airway pressure), or Acapella (vibratory airway clearance device) be used routinely for a general skilled nursing facility or long‑term care patient population who are breathing room air, have no history of pulmonary disease, and are only limited by reduced activity?

Should Incentive Spirometry, ezPAP, or Acapella Be Used Routinely in General SNF/LTC Patients on Room Air Without Lung Disease?

No, these devices should not be used routinely in general skilled nursing facility or long-term care patients who are on room air, have no history of pulmonary disease, and are only limited by reduced activity.

Evidence-Based Rationale

The available guideline evidence clearly indicates these airway clearance devices are not indicated for routine prophylactic use in patients without specific respiratory pathology:

Incentive Spirometry

• Incentive spirometry alone is not recommended for routine use in any setting to prevent pulmonary complications 1
• Studies show no statistically significant advantages when compared to simple deep breathing exercises in low-risk patients 2
• The additional equipment cost is not warranted in patients without elevated risk 2
• Even in postoperative settings with higher risk, incentive spirometry is not recommended for routine prophylactic use 3

ezPAP and Oscillating Devices (Acapella)

The guideline evidence addresses these devices specifically in the context of patients with established respiratory disease:

• Airway clearance therapy is not recommended for routine use in patients without symptomatic secretion retention 3
• These devices are indicated only when patients have specific conditions:
  • Bronchiectasis with productive cough 4
  • COPD with symptomatic secretion retention 3
  • Neuromuscular disease with impaired cough 3
  • Acute respiratory failure requiring ventilatory support 5

Clinical Algorithm for Your Population

For SNF/LTC patients on room air without lung disease:

1. First-line intervention: Early mobilization and ambulation

   • This is the only intervention recommended to reduce complications and promote airway clearance in general populations 3
   • Addresses the decreased activity you describe

2. If patient develops respiratory symptoms:

   • Assess for productive cough or secretion retention
   • If present: Consider simple coached coughing technique 3
   • If absent: Continue mobilization only

3. Reserve devices only for:

   • Patients who develop specific respiratory pathology (pneumonia, COPD exacerbation, bronchiectasis)
   • Patients with neuromuscular weakness and impaired cough (peak cough flow <270 L/min) 3
   • Postoperative patients at high risk (and even then, combined with other interventions, not alone) 1

Key Pitfalls to Avoid

• Do not use these devices as "preventive" therapy in patients without respiratory disease—there is no evidence of benefit
• Do not substitute device therapy for mobilization—early mobility is the evidence-based intervention for your population
• Avoid unnecessary equipment costs when simple interventions (ambulation, deep breathing if needed) are equally or more effective
• Do not assume decreased activity alone warrants respiratory devices—it warrants increased mobilization efforts

Bottom Line

Your general SNF/LTC population breathing room air without pulmonary disease has no indication for routine use of incentive spirometry, ezPAP, or Acapella devices 1, 3. Focus resources on early mobilization and ambulation programs instead, which have actual evidence supporting their use in preventing complications 3.